|
Name |
(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
|
| Molecular Formula | C19H23O6- | |
| IUPAC Name* |
(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
|
|
| SMILES |
C[C@]12[C@H](CC[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)[O-])OC2=O)O
|
|
| InChI |
InChI=1S/C19H24O6/c1-9-7-17-8-18(9,24)5-3-10(17)19-6-4-11(20)16(2,15(23)25-19)13(19)12(17)14(21)22/h10-13,20,24H,1,3-8H2,2H3,(H,21,22)/p-1/t10-,11+,12-,13-,16+,17+,18+,19-/m1/s1
|
|
| InChIKey |
JLJLRLWOEMWYQK-SNTJWBGVSA-M
|
|
| Synonyms |
GA1
|
|
| CAS | NA | |
| PubChem CID | 25202506 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 347.4 | ALogp: | 0.9 |
| HBD: | 2 | HBA: | 6 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 107.0 | Aromatic Rings: | 5 |
| Heavy Atoms: | 25 | QED Weighted: | 0.523 |
| Caco-2 Permeability: | -5.924 | MDCK Permeability: | 0.00001080 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.868 |
| Human Intestinal Absorption (HIA): | 0.03 | 20% Bioavailability (F20%): | 0.965 |
| 30% Bioavailability (F30%): | 0.46 |
| Blood-Brain-Barrier Penetration (BBB): | 0.164 | Plasma Protein Binding (PPB): | 35.65% |
| Volume Distribution (VD): | 0.304 | Fu: | 53.73% |
| CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.925 |
| CYP2C19-inhibitor: | 0.008 | CYP2C19-substrate: | 0.339 |
| CYP2C9-inhibitor: | 0.007 | CYP2C9-substrate: | 0.08 |
| CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.109 |
| CYP3A4-inhibitor: | 0.173 | CYP3A4-substrate: | 0.032 |
| Clearance (CL): | 2.818 | Half-life (T1/2): | 0.472 |
| hERG Blockers: | 0.069 | Human Hepatotoxicity (H-HT): | 0.68 |
| Drug-inuced Liver Injury (DILI): | 0.048 | AMES Toxicity: | 0.009 |
| Rat Oral Acute Toxicity: | 0.948 | Maximum Recommended Daily Dose: | 0.963 |
| Skin Sensitization: | 0.101 | Carcinogencity: | 0.304 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.028 |
| Respiratory Toxicity: | 0.971 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002541 | ![]() |
0.718 | D0R7JT | ![]() |
0.282 | ||
| ENC000794 | ![]() |
0.595 | D0KR5B | ![]() |
0.275 | ||
| ENC000143 | ![]() |
0.563 | D04VIS | ![]() |
0.271 | ||
| ENC002558 | ![]() |
0.528 | D0L2LS | ![]() |
0.267 | ||
| ENC002555 | ![]() |
0.517 | D0IX6I | ![]() |
0.264 | ||
| ENC001071 | ![]() |
0.467 | D0I2SD | ![]() |
0.259 | ||
| ENC002554 | ![]() |
0.441 | D0Q6NZ | ![]() |
0.252 | ||
| ENC002556 | ![]() |
0.371 | D0D1SG | ![]() |
0.252 | ||
| ENC002559 | ![]() |
0.360 | D06AEO | ![]() |
0.252 | ||
| ENC003162 | ![]() |
0.289 | D0P0HT | ![]() |
0.250 | ||